No Data
No Data
Kashitang: 2024 Semi-Annual Report
Jiashitang: Summary of the 2024 Semi-Annual Report
Cachet Pharmaceutical (002462.SZ): net income of 0.168 billion yuan in the first half of the year, a year-on-year increase of 8.19%.
Cachet Pharmaceutical (002462.SZ) announced its interim report for the first half of 2024, with a reported revenue of 12.839 billion yuan, a year-on-year decrease of 13.70%; net income attributable to the shareholders of the listed company was 0.168 billion yuan, a year-on-year increase of 8.19%; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.107 billion yuan, a year-on-year decrease of 28.38%; basic earnings per share were 0.58 yuan.
Cachet Pharmaceutical (002462.SZ) announced its performance for the first half of the year, with a net income of 0.168 billion yuan, an 8.19% increase.
Cachet Pharmaceutical (002462.SZ) released its 2024 interim report. During the reporting period, the company achieved revenue of 1...
Cachet Pharmaceutical Chairman Resigns
Cachet Pharmaceutical (002462.SZ) announced the resignation of its director and chairman of the board, Xu Wenli.
Cachet Pharmaceutical (002462.SZ) announced that its chairman, Xu Wenli, resigned from the company due to internal work adjustments within the group in a recent announcement.
No Data